In recent years, GLP‑1-based treatments for obesity have evolved from being primarily a diabetes-focused strategy to becoming a powerful tool for managing weight and reducing cardiometabolic risk—especially in individuals without type 2 diabetes. This growing trend is shifting how clinicians identify and manage obesity, moving beyond A1C levels to a …
Read More »Exploring the Microbiome’s Role in Obesity and Diabetes
The microbiome, the complex ecosystem of microorganisms that live in and on the human body, has been linked to a variety of health conditions, including obesity and diabetes. In recent years, researchers have been exploring the microbiome’s role in these conditions, in order to better understand the connection between them. …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.